Skip to navigation Skip to content



Researchers Funded by the National MS Society Report Jumpstarting Myelin Repair and Restoring Function in Mice

April 6, 2017

An experimental therapy succeeded in promoting the formation of nerve-insulating myelin and improving limb function in mice with an MS-like disease. The agent, miR-219, is a “microRNA,” a short segment of genetic material that is involved in turning on or off cell activity. These findings were reported by researchers from Cincinnati Children’s Hospital Medical Center, who were funded by the National MS Society and the  National Institutes of Health. The team is continuing to test this and similar molecules for their potential to repair myelin in the lab, a necessary step before being developed as a treatment to repair myelin in people with MS.

Read more about this study on Neuroscience News

Read the scientific summary (abstract) of the study in Developmental Cell

Read more about research to repair myelin in MS


About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. Symptoms range from numbness and tingling to blindness and paralysis, and there is currently no cure for MS. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. An estimated 1 million people live with MS in the United States. Most people with MS are diagnosed between the ages of 20 and 50, and it affects women three times more than men.


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.